Pharma gets smart & lean
October 22, 2003Research and Development pharma, strategy
Pharmaceutical companies need to transform themselves into more flexible and connected entities and given the financial pressures on the sector …
EDC – turning the corner?
October 22, 2003Research and Development EDC, drug development, electronic data capture, technology
Electronic Data Capture is a way of eliminating paper in the data collection process by capturing the data directly into …
European biotech – surviving the storm
October 22, 2003Research and Development Europe, biotech, investment
Flexibility and constant adjustment are necessary to survive one of the toughest times in the history of the industry.There have …
A smoother ride to market
October 22, 2003Research and Development clinical development, patient recruitment
The concepts of the 'business case' and 'performance management' have become popular even outside business circles, but clinical trials for …
NHS pay rise linked to reform
October 22, 2003Workers throughout the NHS are to receive substantial pay rises in return for undergoing radical ob evaluationreviews over the next …
Novartis files COX-II contender amid class safety concerns
October 22, 2003Novartis has submitted its COX-II inhibitor Prexige to US and European regulators with data from 13,000 clinical trial patients to …
Supplementary prescribing gets go ahead
October 22, 2003Thousands of trained pharmacists and nurses will be able to prescribe drugs for chronic diseases by late 2004, the Government …
Increase marketing RoI or cut back, analysts warn
October 22, 2003Pharmaceutical companies must make their sales and marketing more cost-effective or cut back, according to a new report.Analysts Datamonitor warn …
OGS extends Actelion relationship as Zavesca approved
October 22, 2003Oxford GlycoSciences has announced the EU approval of its first product, Zavesca, and an extension to its co-marketing agreement with …
Red tape could suffocate European clinical trials
October 22, 2003New measures intended to improve the competitiveness of clinical trials in Europe could have the opposite effect, a leading research …
BMS schizophrenia drug wins US approval
October 22, 2003New atypical antipsychotic Abilify has gained FDA approval for the treatment of schizophrenia and is tipped to eventually become a …
National service framework leaders appointed
October 22, 2003Key appointments for the Children's National Service Framework and the Long-term Conditions National Service Framework have been announced.The external working …
Government presses on with MCA merger
October 22, 2003The UK Government is to press ahead with the merger of the Medicines Control Agency and its medical devices counterpart …
Bayer parallel import case reopened
October 22, 2003A landmark legal battle over parallel trade of Bayer's blood pressure treatment Adalat has been re-commenced in the European Court …
New Bextra warnings add to COX-II doubts
October 22, 2003New warnings on the label of second-generation COX-II inhibitor Bextra have added to doubts about the safety of the drug …
Latest content
FibroFind appoints Lee Borthwick as CEO
